ReviewMaterials today. Bio2026
Recent advances in nanocellulose scaffold membranes: Sources, processing and functionalization.
Review in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanocellulose, derived from renewable cellulose resources, has emerged as a highly promising candidate for biomedical scaffold membrane applications owing to its excellent mechanical properties, tunable surface chemistry, biodegradability, and biocompatibility. The performance of nanocellulose-based membrane materials can be significantly enhanced through the integrated regulation of raw material sources, processing and functionalization. This review provides a comprehensive overview of the advances in nanocellulose scaffold membranes from raw material sources, processing technologies, functionalization strategies and biomedical applications. The review especially focuses on how to synergistically integrate these parameters to achieve a balanced design for customizable membranes. Furthermore, a design-oriented conceptual framework for the fabrication of regenerated nanocellulose composite membranes by electrospinning is discussed, which can provide guidance for future material and process development. Despite the preliminary progress achieved to date, several critical bottlenecks continue to hinder practical implementation, including difficulties in pore-structure regulation, long-term biosafety assessment, standardized large-scale manufacturing, and cost-effective production. Overall, this review not only summarizes the latest advancements in nanocellulose-based scaffold membranes, but also points out a future direction for their rational design and biomedical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.